Evaluation of, delivery of, and use of agents to treat heart disorders
CA 2297328 A1 · Owner: Guerrero, Luis · Inventors: Hajjar, Roger J.; Rosenzweig, Anthony; Guerrero, Luis
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods of evaluating a tratement for a heart disorder. The invention also provides methods of delivering a compound to the heart of a subject. A heart cell, into which has been introduced by somatic gene transfer, a nucleic acid which results in the expression of phospholamban a , heart tissue, into which has been introduced by somatic gene transfer a , nucleic acid which results in the expression of phospholamban and a heart into which has been introduced by somatic gene transfer a nucleic acid which , results in the expression of phospholamban are also provided by the invention. Finally, the invention provides a method for treating a subject at risk for a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 20, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 20, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 20, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.